However, BCAT1 expression in non IDH or TET2 mutant AML stem cells correlates with decreased α-KG levels and gene expression profiles similar to IDH mutant cells, suggesting deregulation of methylation regulated by TET2 (113). This evidence concerns the gene IDH2 and acute myeloid leukemia.